These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2350531)

  • 21. In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes.
    Yenes S; Commandeur JN; Vermeulen NP; Messeguer A
    Chem Res Toxicol; 2004 Jul; 17(7):904-13. PubMed ID: 15257615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regioselectivity of hydroxylation of prostaglandins by liver microsomes supported by NADPH versus H2O2 in methylcholanthrene-treated and control rats: formation of novel prostaglandin metabolites.
    Holm KA; Engell RJ; Kupfer D
    Arch Biochem Biophys; 1985 Mar; 237(2):477-89. PubMed ID: 3856417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxylation of 4,4'-methylenebis(2-chloroaniline) by canine, guinea pig, and rat liver microsomes.
    Chen TH; Kuslikis BI; Braselton WE
    Drug Metab Dispos; 1989; 17(4):406-13. PubMed ID: 2571481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The oxidative metabolism of hydralazine by rat liver microsomes.
    LaCagnin LB; Colby HD; O'Donnell JP
    Drug Metab Dispos; 1986; 14(5):549-54. PubMed ID: 2876860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
    Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
    Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro metabolism of the antianxiety drug buspirone as a predictor of its metabolism in vivo.
    Jajoo HK; Blair IA; Klunk LJ; Mayol RF
    Xenobiotica; 1990 Aug; 20(8):779-86. PubMed ID: 2219961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes.
    Lovern MR; Turner MJ; Meyer M; Kedderis GL; Bechtold WE; Schlosser PM
    Carcinogenesis; 1997 Sep; 18(9):1695-700. PubMed ID: 9328163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new pathway for the oxidative metabolism of chloramphenicol by rat liver microsomes.
    Morris PL; Burke TR; George JW; Pohl LR
    Drug Metab Dispos; 1982; 10(5):439-45. PubMed ID: 6128189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice.
    Ahn S; Kearbey JD; Li CM; Duke CB; Miller DD; Dalton JT
    Drug Metab Dispos; 2011 Apr; 39(4):636-43. PubMed ID: 21233217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites.
    Zhang Z; Chen Q; Li Y; Doss GA; Dean BJ; Ngui JS; Silva Elipe M; Kim S; Wu JY; Dininno F; Hammond ML; Stearns RA; Evans DC; Baillie TA; Tang W
    Chem Res Toxicol; 2005 Apr; 18(4):675-85. PubMed ID: 15833027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol metabolism by human liver in vitro--I. Metabolite identification and inter-individual variability.
    Abel SM; Maggs JL; Back DJ; Park BK
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):713-9. PubMed ID: 1472463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aerobic 2- and 4-nitroreduction of CB 1954 by human liver.
    Tang MH; Helsby NA; Wilson WR; Tingle MD
    Toxicology; 2005 Dec; 216(2-3):129-39. PubMed ID: 16129536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes.
    Lim CK; Yuan ZX; Lamb JH; White IN; De Matteis F; Smith LL
    Carcinogenesis; 1994 Apr; 15(4):589-93. PubMed ID: 8149466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of 14C-toluene to covalently binding metabolites by rat liver microsomes.
    Pathiratne A; Puyear RL; Brammer JD
    Drug Metab Dispos; 1986; 14(4):386-91. PubMed ID: 2873983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
    Gentile DM; Verhoeven CH; Shimada T; Back DJ
    J Pharmacol Exp Ther; 1998 Dec; 287(3):975-82. PubMed ID: 9864282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.